[{"address1": "11 Deer Park Drive", "address2": "Suite 204", "city": "Monmouth Junction", "state": "NJ", "zip": "08512", "country": "United States", "phone": "609 495 2200", "website": "https://palatin.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey.", "fullTimeEmployees": 29, "companyOfficers": [{"maxAge": 1, "name": "Dr. Carl  Spana Ph.D.", "age": 62, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1962, "fiscalYear": 2025, "totalPay": 738500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Burns  McClellan", "title": "Vice President of Investor Relations", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stephen A. Slusher Esq.", "title": "Chief Legal Officer", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael B. Raizman M.D.", "title": "Chief Medical Officer", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James E. Hattersley B.A., M.S.", "age": 64, "title": "Senior Vice President of Business Development", "yearBorn": 1960, "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John  Dodd Ph.D.", "title": "Senior Vice President of Preclinical Development", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Jordan", "title": "Senior Vice President of Program Operations", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 14.49, "open": 10.25, "dayLow": 8.54, "dayHigh": 12.21, "regularMarketPreviousClose": 14.49, "regularMarketOpen": 10.25, "regularMarketDayLow": 8.54, "regularMarketDayHigh": 12.21, "payoutRatio": 0.0, "beta": -0.179, "volume": 26630, "regularMarketVolume": 26630, "averageVolume": 21774, "averageVolume10days": 119958, "averageDailyVolume10Day": 119958, "bid": 10.25, "ask": 10.5, "bidSize": 10000, "askSize": 54100, "marketCap": 38855044, "fiftyTwoWeekLow": 1.75, "fiftyTwoWeekHigh": 72.5, "allTimeHigh": 4375000.0, "allTimeLow": 1.75, "fiftyDayAverage": 8.778202, "twoHundredDayAverage": 14.050033, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 18622676, "profitMargins": 0.0, "floatShares": 1931827, "sharesOutstanding": 1702675, "sharesShort": 38596, "sharesShortPriorMonth": 46851, "sharesShortPreviousMonthDate": 1743379200, "dateShortInterest": 1745971200, "sharesPercentSharesOut": 0.067600004, "heldPercentInsiders": 0.01952, "heldPercentInstitutions": 2.0000001e-05, "shortRatio": 0.79, "shortPercentOfFloat": 0.0686, "impliedSharesOutstanding": 973291, "bookValue": -5.139, "lastFiscalYearEnd": 1751241600, "nextFiscalYearEnd": 1782777600, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -17307348, "trailingEps": -32.15, "lastSplitFactor": "1:50", "lastSplitDate": 1754956800, "enterpriseToEbitda": -0.83, "52WeekChange": -0.62616825, "SandP52WeekChange": 0.1326145, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "PTNT", "underlyingSymbol": "PTNT", "shortName": "Palatin Technologies, Inc.", "longName": "Palatin Technologies, Inc.", "firstTradeDateEpochUtc": 783613800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "31665049-713c-3ebb-aa5c-18f875ea1380", "messageBoardId": "finmb_32651", "gmtOffSetMilliseconds": -18000000, "currentPrice": 22.82, "recommendationKey": "none", "totalCash": 2564265, "totalCashPerShare": 1.317, "ebitda": -22448922, "totalDebt": 163781, "quickRatio": 0.324, "currentRatio": 0.364, "returnOnAssets": -2.02615, "grossProfits": -14898494, "freeCashflow": -14024390, "operatingCashflow": -21306636, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-11-29"}]